Your browser doesn't support javascript.
loading
Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with p53 Deficiency.
Jiang, Zong-Yuan; Hong, Jiang; Zhang, Ju-Hua; Wang, Xiao-Feng; Ma, Yu-Shui; Xiong, Zhang-Xia; Sun, Hao-Ran; Cheng, Cong; Xie, Bang-Zhu; Liu, Ji-Bin; Ouyang, Yang-Gang; Fu, Da.
Afiliação
  • Jiang ZY; Affiliated Longhua People's Hospital, 70570Southern Medical University, Shenzhen, China.
  • Hong J; Navy Military Medical University Affiliated 12520Changhai Hospital, Shanghai, China.
  • Zhang JH; 12478Fudan University, Shanghai, China.
  • Wang XF; Shanghai Pudong Health Development Research Institute, Shanghai, China.
  • Ma YS; Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.
  • Xiong ZX; Zhongshan Hospital, 12478Fudan University, Shanghai, China.
  • Sun HR; Cancer Institute, Nantong Tumor Hospital, Nantong, China.
  • Cheng C; Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Xie BZ; Affiliated Longhua People's Hospital, 70570Southern Medical University, Shenzhen, China.
  • Liu JB; Affiliated Longhua People's Hospital, 70570Southern Medical University, Shenzhen, China.
  • Ouyang YG; Affiliated Longhua People's Hospital, 70570Southern Medical University, Shenzhen, China.
  • Fu D; Affiliated Longhua People's Hospital, 70570Southern Medical University, Shenzhen, China.
Technol Cancer Res Treat ; 21: 15330338221119745, 2022.
Article em En | MEDLINE | ID: mdl-35971329

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidonas / Complexo de Endopeptidases do Proteassoma Limite: Animals / Humans Idioma: En Revista: Technol Cancer Res Treat Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidonas / Complexo de Endopeptidases do Proteassoma Limite: Animals / Humans Idioma: En Revista: Technol Cancer Res Treat Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China